Guiyuan Q. Li

No. 100, Haining Road
Hongkou, 200080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 357 publications

LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.

LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.

Journal: Journal for immunotherapy of cancer

Published: August 05, 2026

[Expression of Concern] Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.

[Expression of Concern] Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.

Journal: Oncology letters

Published: July 25, 2026

The cGAS-STING pathway in cancer: friend or foe.

The cGAS-STING pathway in cancer: friend or foe.

Journal: Cell death & disease

Published: September 09, 2025

Pseudouridine synthases upregulate 5'-tRF-Lys to inhibit YPEL3 and drive malignant progression in nasopharyngeal carcinoma.

Pseudouridine synthases upregulate 5'-tRF-Lys to inhibit YPEL3 and drive malignant progression in nasopharyngeal carcinoma.

Journal: Cellular & molecular biology letters

Published: August 21, 2025

Research on the resilience of ecological networks from the perspective of ecological security pattern: a case study of Wuhan metropolitan area.

Research on the resilience of ecological networks from the perspective of ecological security pattern: a case study of Wuhan metropolitan area.

Journal: Scientific reports

Published: July 06, 2025

Retraction: Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer.

Retraction: Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer.

Journal: Oncotarget

Published: May 12, 2025

TRIM25 degrades BRD7 protein stability through the ubiquitin proteasome pathway to promote breast cancer progression and paclitaxel resistance by activating YB1/Bcl-2 transcription axis.

TRIM25 degrades BRD7 protein stability through the ubiquitin proteasome pathway to promote breast cancer progression and paclitaxel resistance by activating YB1/Bcl-2 transcription axis.

Journal: Cell death & disease

Published: February 18, 2025

A moonlighting function of tumoral interleukin-1β precursor promotes metastasis via RACK1-mediated actin remodeling.

A moonlighting function of tumoral interleukin-1β precursor promotes metastasis via RACK1-mediated actin remodeling.

Journal: Nature communications

Published: February 15, 2025

High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variant.

High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variant.

Journal: Nature communications

Published: January 07, 2025

Prediction of recurrence-free survival in patients with invasive ductal carcinoma of the breast on the basis of clinicopathological, conventional ultrasound and contrast-enhanced ultrasound imaging characteristics.

Prediction of recurrence-free survival in patients with invasive ductal carcinoma of the breast on the basis of clinicopathological, conventional ultrasound and contrast-enhanced ultrasound imaging characteristics.

Journal: Clinical radiology

Published: December 24, 2024

Nanocarriers Targeting Circular RNA ADARB1 Boost Radiosensitivity of Nasopharyngeal Carcinoma through Synergically Promoting Ferroptosis.

Nanocarriers Targeting Circular RNA ADARB1 Boost Radiosensitivity of Nasopharyngeal Carcinoma through Synergically Promoting Ferroptosis.

Journal: ACS nano

Published: October 28, 2024

FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.

FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.

Journal: Journal for immunotherapy of cancer

Published: October 23, 2024

Showing 1-12 of 357

Last Updated: 09/26/2026